{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T01:51:49Z","timestamp":1790387509173,"version":"4.1.0"},"reference-count":40,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T00:00:00Z","timestamp":1539907200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["2018R1A2B2005390"],"award-info":[{"award-number":["2018R1A2B2005390"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003621","name":"Ministry of Science, ICT and Future Planning","doi-asserted-by":"publisher","award":["2017R1C1B2004989"],"award-info":[{"award-number":["2017R1C1B2004989"]}],"id":[{"id":"10.13039\/501100003621","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Hepatitis C virus (HCV) exploits an extensive network of host proteins to maintain chronic infection. Using RNA-Seq technology, we identified 30 host genes that were differentially expressed in cell culture grown HCV (HCVcc)-infected cells. Of these candidate genes, we selected solute carrier family 3 member 2 (SLC3A2) for further investigation. SLC3A2, also known as CD98hc, is a member of the solute carrier family and encodes a subunit of heterodimeric amino acid transporter. SLC3A2 and LAT1 constitute a heterodimeric transmembrane protein complex that catalyzes amino acid transport. In this study, we showed that HCV upregulated both mRNA and protein expression levels of SLC3A2 and this upregulation occurred through NS3\/4A-mediated oxidative stress. HCV also elevated SLC3A2\/LAT1 complex level and thus mammalian target of rapamycin complex 1 (mTORC1) signaling was activated. We further showed that L-leucine transport level was significantly increased in Jc1-infected cells as compared with mock-infected cells. Using RNA interference technology, we demonstrated that SLC3A2 was specifically required for the entry step but not for other stages of the HCV life cycle. These data suggest that SLC3A2 plays an important role in regulating HCV entry. Collectively, HCV exploits SLC3A2 for viral propagation and upregulation of SLC3A2 may contribute to HCV-mediated pathogenesis.<\/jats:p>","DOI":"10.1038\/s41598-018-33861-6","type":"journal-article","created":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T10:27:08Z","timestamp":1539599228000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Hepatitis C Virus Modulates Solute carrier family 3 member 2 for Viral Propagation"],"prefix":"10.1038","volume":"8","author":[{"given":"Ngan N. T.","family":"Nguyen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun-Sook","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lap P.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si C.","family":"Tran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trang T. D.","family":"Luong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tram T. T.","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hang T.","family":"Pham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han N.","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jae-Woong","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang-Seop","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soon B.","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,10,19]]},"reference":[{"key":"33861_CR1","doi-asserted-by":"publisher","first-page":"S45","DOI":"10.1016\/j.jhep.2014.07.027","volume":"61","author":"E Gower","year":"2014","unstructured":"Gower, E., Estes, C., Blach, S., Razavi-Shearer, K. & Razavi, H. Global epidemiology and genotype distribution of the hepatitis C virus infection. J. Hepatol. 61, S45\u201357 (2014).","journal-title":"J. Hepatol."},{"key":"33861_CR2","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1016\/j.addr.2007.04.014","volume":"59","author":"T Suzuki","year":"2007","unstructured":"Suzuki, T., Ishii, K., Aizaki, H. & Wakita, T. Hepatitis C viral life cycle. Adv. Drug Deliv. Rev. 59, 1200\u20131212 (2007).","journal-title":"Adv. Drug Deliv. Rev."},{"key":"33861_CR3","doi-asserted-by":"publisher","first-page":"1124","DOI":"10.1016\/S0140-6736(14)62401-6","volume":"385","author":"DP Webster","year":"2015","unstructured":"Webster, D. P., Klenerman, P. & Dusheiko, G. M. Hepatitis C. Lancet 385, 1124\u20131135 (2015).","journal-title":"Lancet"},{"key":"33861_CR4","doi-asserted-by":"publisher","first-page":"1373","DOI":"10.1242\/jcs.096040","volume":"125","author":"JM Cantor","year":"2012","unstructured":"Cantor, J. M. & Ginsberg, M. H. CD98 at the crossroads of adaptive immunity and cancer. J. Cell Sci. 125, 1373\u20131382 (2012).","journal-title":"J. Cell Sci."},{"key":"33861_CR5","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.biocel.2016.11.005","volume":"81","author":"H Ip","year":"2016","unstructured":"Ip, H. & Sethi, T. CD98 signals controlling tumorigenesis. Int. J. Biochem. Cell. Biol. 81, 148\u2013150 (2016).","journal-title":"Int. J. Biochem. Cell. Biol."},{"key":"33861_CR6","doi-asserted-by":"publisher","first-page":"9700","DOI":"10.1074\/jbc.M115.704254","volume":"291","author":"LR de la Ballina","year":"2016","unstructured":"de la Ballina, L. R. et al. Amino acid transport associated to cluster of differentiation 98 heavy chain (CD98hc) is at the cross-road of oxidative stress and amino acid availability. J. Biol. Chem. 291, 9700\u20139711 (2016).","journal-title":"J. Biol. Chem."},{"key":"33861_CR7","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.1152\/ajpcell.2001.281.4.C1077","volume":"281","author":"CA Wagner","year":"2001","unstructured":"Wagner, C. A., Lang, F. & Broer, S. Function and structure of heterodimeric amino acid transporters. Am. J. Physiol. Cell physiol. 281, 1077\u20131093 (2001).","journal-title":"Am. J. Physiol. Cell physiol."},{"key":"33861_CR8","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1152\/physrev.1998.78.4.969","volume":"78","author":"M Palacin","year":"1998","unstructured":"Palacin, M., Estevez, R., Bertran, J. & Zorzano, A. Molecular biology of mammalian plasma membrane amino acid transporters. Physiol. Rev. 78, 969\u20131054 (1998).","journal-title":"Physiol. Rev."},{"key":"33861_CR9","doi-asserted-by":"publisher","DOI":"10.1186\/1476-4598-12-169","volume":"12","author":"M Poettler","year":"2013","unstructured":"Poettler, M. et al. CD98hc (SLC3A2) drives integrin-dependent renal cancer cell behavior. Mol. Cancer 12, 169 (2013).","journal-title":"Mol. Cancer"},{"key":"33861_CR10","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1073\/pnas.0404852102","volume":"102","author":"CC Feral","year":"2005","unstructured":"Feral, C. C. et al. CD98hc (SLC3A2) mediates integrin signaling. Proc. Natl. Acad. Sci. USA 102, 355\u2013360 (2005).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33861_CR11","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1016\/j.cell.2008.11.044","volume":"136","author":"P Nicklin","year":"2009","unstructured":"Nicklin, P. et al. Bidirectional transport of amino acids regulates mTOR and autophagy. Cell 136, 521\u2013534 (2009).","journal-title":"Cell"},{"key":"33861_CR12","doi-asserted-by":"publisher","DOI":"10.1038\/srep20819","volume":"6","author":"TT Than","year":"2016","unstructured":"Than, T. T. et al. Ankyrin repeat domain 1 is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry. Sci. Rep. 6, 20819 (2016).","journal-title":"Sci. Rep."},{"key":"33861_CR13","doi-asserted-by":"publisher","first-page":"7408","DOI":"10.1073\/pnas.0504877103","volume":"103","author":"T Pietschmann","year":"2006","unstructured":"Pietschmann, T. et al. Construction and characterization of infectious intragenotypic and intergenotypic hepatitis C virus chimeras. Proc. Natl. Acad. Sci. USA 103, 7408\u20137413 (2006).","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"33861_CR14","doi-asserted-by":"publisher","first-page":"439","DOI":"10.3390\/v5020439","volume":"5","author":"AV Ivanov","year":"2013","unstructured":"Ivanov, A. V., Bartosch, B., Smirnova, O. A., Isaguliants, M. G. & Kochetkov, S. N. HCV and oxidative stress in the liver. Viruses 5, 439\u2013469 (2013).","journal-title":"Viruses"},{"issue":"Suppl 3","key":"33861_CR15","doi-asserted-by":"publisher","first-page":"S34","DOI":"10.1111\/j.1440-1746.2006.04591.x","volume":"21","author":"T Wang","year":"2006","unstructured":"Wang, T. & Weinman, S. A. Causes and consequences of mitochondrial reactive oxygen species generation in hepatitis C. J. Gastroenterol. Hepatol. 21(Suppl 3), S34\u201337 (2006).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"33861_CR16","doi-asserted-by":"publisher","first-page":"2474","DOI":"10.1096\/fj.06-7345com","volume":"21","author":"Y Li","year":"2007","unstructured":"Li, Y., Boehning, D. F., Qian, T., Popov, V. L. & Weinman, S. A. Hepatitis C virus core protein increases mitochondrial ROS production by stimulation of Ca2+ uniporter activity. FASEB J. 21, 2474\u20132485 (2007).","journal-title":"FASEB J."},{"key":"33861_CR17","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/j.jhep.2005.04.019","volume":"43","author":"MV Garcia-Mediavilla","year":"2005","unstructured":"Garcia-Mediavilla, M. V. et al. Differential contribution of hepatitis C virus NS5A and core proteins to the induction of oxidative and nitrosative stress in human hepatocyte-derived cells. J. Hepatol. 43, 606\u2013613 (2005).","journal-title":"J. Hepatol."},{"key":"33861_CR18","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1111\/j.1440-1746.2009.06128.x","volume":"25","author":"S Pal","year":"2010","unstructured":"Pal, S. et al. Hepatitis C virus induces oxidative stress, DNA damage and modulates the DNA repair enzyme NEIL1. J. Gastroenterol. Hepatol. 25, 627\u2013634 (2010).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"33861_CR19","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","volume":"67","author":"L Napolitano","year":"2015","unstructured":"Napolitano, L. et al. LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter. Int. J. Biochem. Cell Biol. 67, 25\u201333 (2015).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"33861_CR20","doi-asserted-by":"publisher","first-page":"8705","DOI":"10.1128\/JVI.00616-12","volume":"86","author":"S Shrivastava","year":"2012","unstructured":"Shrivastava, S., Bhanja Chowdhury, J., Steele, R., Ray, R. & Ray, R. B. Hepatitis C virus upregulates Beclin1 for induction of autophagy and activates mTOR signaling. J. Virol. 86, 8705\u20138712 (2012).","journal-title":"J. Virol."},{"key":"33861_CR21","doi-asserted-by":"publisher","first-page":"5042","DOI":"10.1074\/jbc.M111.308916","volume":"287","author":"A George","year":"2012","unstructured":"George, A. et al. Hepatitis C virus NS5A binds to the mRNA cap-binding eukaryotic translation initiation 4F (eIF4F) complex and up-regulates host translation initiation machinery through eIF4E-binding protein 1 inactivation. J. Biol. Chem. 287, 5042\u20135058 (2012).","journal-title":"J. Biol. Chem."},{"key":"33861_CR22","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1016\/j.ejcb.2017.03.013","volume":"96","author":"A Batool","year":"2017","unstructured":"Batool, A., Aashaq, S. & Andrabi, K. I. Reappraisal to the study of 4E-BP1 as an mTOR substrate-A normative critique. Eur. J. Cell Biol. 96, 325\u2013336 (2017).","journal-title":"Eur. J. Cell Biol."},{"key":"33861_CR23","doi-asserted-by":"publisher","first-page":"10073","DOI":"10.1128\/JVI.01707-15","volume":"89","author":"C Park","year":"2015","unstructured":"Park, C. et al. Pim kinase interacts with nonstructural 5A protein and regulates hepatitis C virus entry. J. Virol. 89, 10073\u201310086 (2015).","journal-title":"J. Virol."},{"key":"33861_CR24","first-page":"1281","volume":"5","author":"Q Wang","year":"2015","unstructured":"Wang, Q. & Holst, J. L-type amino acid transport and cancer: targeting the mTORC1 pathway to inhibit neoplasia. Amer. J. Cancer Res. 5, 1281\u20131294 (2015).","journal-title":"Amer. J. Cancer Res."},{"key":"33861_CR25","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1111\/j.1365-2362.2009.02096.x","volume":"39","author":"GW Prager","year":"2009","unstructured":"Prager, G. W. et al. CD98hc (SLC3A2), a novel marker in renal cell cancer. Eur. J. Clin. Invest. 39, 304\u2013310 (2009).","journal-title":"Eur. J. Clin. Invest."},{"key":"33861_CR26","doi-asserted-by":"publisher","first-page":"E1329","DOI":"10.1152\/ajpendo.00525.2011","volume":"302","author":"KM Dodd","year":"2012","unstructured":"Dodd, K. M. & Tee, A. R. Leucine and mTORC1: a complex relationship. Am. J. Physiol. Endocrinol Metab 302, E1329\u20131342 (2012).","journal-title":"Am. J. Physiol. Endocrinol Metab"},{"key":"33861_CR27","doi-asserted-by":"publisher","first-page":"498","DOI":"10.2174\/1568009616666160926124043","volume":"17","author":"N Fu","year":"2017","unstructured":"Fu, N., Yao, H., Nan, Y. & Qiao, L. Role of Oxidative stress in hepatitis C virus induced hepatocellular carcinoma. Curr. Cancer Drug. Targets. 17, 498\u2013504 (2017).","journal-title":"Curr. Cancer Drug. Targets."},{"key":"33861_CR28","doi-asserted-by":"publisher","first-page":"9012580","DOI":"10.1155\/2016\/9012580","volume":"2016","author":"R Medvedev","year":"2016","unstructured":"Medvedev, R., Ploen, D. & Hildt, E. HCV and oxidative stress: Implications for HCV life cycle and HCV-associated pathogenesis. Oxid. Med. Cell. Longev. 2016, 9012580 (2016).","journal-title":"Oxid. Med. Cell. Longev."},{"key":"33861_CR29","doi-asserted-by":"publisher","first-page":"20870","DOI":"10.1074\/jbc.M110.112045","volume":"285","author":"L Peng","year":"2010","unstructured":"Peng, L., Liang, D., Tong, W., Li., J. & Yuan, Z. Hepatitis C virus NS5A activates the mammalian target of rapamycin (mTOR) pathway, contributing to cell survival by disrupting the interaction between FK506-binding protein 38 (FKBP38) and mTOR. J. Biol. Chem. 285, 20870\u201320881 (2010).","journal-title":"J. Biol. Chem."},{"key":"33861_CR30","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1038\/nature05654","volume":"446","author":"MJ Evans","year":"2007","unstructured":"Evans, M. J. et al. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446, 801\u2013805 (2007).","journal-title":"Nature"},{"key":"33861_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1038\/nrmicro3098","volume":"11","author":"BD Lindenbach","year":"2013","unstructured":"Lindenbach, B. D. & Rice, C. M. The ins and outs of hepatitis C virus entry and assembly. Nat. Rev. Microbiol. 11, 688\u2013700 (2013).","journal-title":"Nat. Rev. Microbiol."},{"key":"33861_CR32","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/nm.3248","volume":"19","author":"TK Scheel","year":"2013","unstructured":"Scheel, T. K. & Rice, C. M. Understanding the hepatitis C virus life cycle paves the way for highly effective therapies. Nat. Med. 19, 837\u2013849 (2013).","journal-title":"Nat. Med."},{"key":"33861_CR33","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1002\/hep.26097","volume":"57","author":"MN Zahid","year":"2013","unstructured":"Zahid, M. N. et al. The postbinding activity of scavenger receptor class B type I mediates initiation of hepatitis C virus infection and viral dissemination. Hepatology 57, 492\u2013504 (2013).","journal-title":"Hepatology"},{"key":"33861_CR34","doi-asserted-by":"publisher","first-page":"11331","DOI":"10.1128\/JVI.00104-06","volume":"80","author":"M Flint","year":"2006","unstructured":"Flint, M. et al. Diverse CD81 proteins support hepatitis C virus infection. J. Virol. 80, 11331\u201311342 (2006).","journal-title":"J. Virol."},{"key":"33861_CR35","doi-asserted-by":"publisher","first-page":"30361","DOI":"10.1074\/jbc.M111.263350","volume":"286","author":"NR Sharma","year":"2011","unstructured":"Sharma, N. R. et al. Hepatitis C virus is primed by CD81 protein for low pH-dependent fusion. J. Biol. Chem. 286, 30361\u201330376 (2011).","journal-title":"J. Biol. Chem."},{"key":"33861_CR36","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.virol.2012.03.002","volume":"429","author":"YZ Zhu","year":"2012","unstructured":"Zhu, Y. Z. et al. Significance of palmitoylation of CD81 on its association with tetraspanin-enriched microdomains and mediating hepatitis C virus cell entry. Virology 429, 112\u2013123 (2012).","journal-title":"Virology"},{"key":"33861_CR37","doi-asserted-by":"publisher","first-page":"3457","DOI":"10.3748\/wjg.v20.i13.3457","volume":"20","author":"YZ Zhu","year":"2014","unstructured":"Zhu, Y. Z., Qian, X. J., Zhao, P. & Qi, Z. T. How hepatitis C virus invades hepatocytes: the mystery of viral entry. World J. Gastroenterol. 20, 3457\u20133467 (2014).","journal-title":"World J. Gastroenterol."},{"key":"33861_CR38","doi-asserted-by":"publisher","first-page":"4868","DOI":"10.1128\/JVI.06610-11","volume":"86","author":"N Schroeder","year":"2012","unstructured":"Schroeder, N., Chung, C. S., Chen, C. H., Liao, C. L. & Chang, W. The lipid raft-associated protein CD98 is required for vaccinia virus endocytosis. J. Virol. 86, 4868\u20134882 (2012).","journal-title":"J. Virol."},{"key":"33861_CR39","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.3389\/fmicb.2017.01129","volume":"8","author":"S Min","year":"2017","unstructured":"Min, S. et al. Abl tyrosine kinase regulates hepatitis C virus entry. Front Microbiol. 8, 1129 (2017).","journal-title":"Front Microbiol."},{"key":"33861_CR40","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/j.aninu.2017.12.002","volume":"3","author":"T Wang","year":"2018","unstructured":"Wang, T. et al. L-leucine stimulates glutamate dehydrogenase activity and glutamate synthesis by regulating mTORC1\/SIRT4 pathway in pig liver. Anim. Nutr. 3, 329\u2013337 (2018).","journal-title":"Anim. Nutr."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33861-6","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33861-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,21]],"date-time":"2022-12-21T10:49:04Z","timestamp":1671619744000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-33861-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,19]]},"references-count":40,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2018,12]]}},"alternative-id":["33861"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-33861-6","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,19]]},"assertion":[{"value":"20 July 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 October 2018","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"15486"}}